TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Croda International ( (GB:CRDA) ) has provided an update.
Croda International Plc has announced a series of share transactions involving its key managerial personnel under the company’s Share Incentive Plan. The transactions, conducted on November 10, 2025, involved the purchase of partnership shares and the awarding of matching shares to executives and committee members, reflecting the company’s commitment to aligning management interests with shareholder value. This move is likely to strengthen the company’s internal stakeholder engagement and enhance its market positioning by incentivizing its leadership team.
The most recent analyst rating on (GB:CRDA) stock is a Buy with a £31.50 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.
Spark’s Take on GB:CRDA Stock
According to Spark, TipRanks’ AI Analyst, GB:CRDA is a Outperform.
Croda International’s overall stock score reflects strong earnings call performance and positive technical indicators. Financial performance is stable but challenged by declining margins. Valuation is a concern due to a high P/E ratio, though the dividend yield offers some compensation.
To see Spark’s full report on GB:CRDA stock, click here.
More about Croda International
Croda International Plc is a global specialty chemicals company that focuses on the development and production of high-performance ingredients and technologies. The company serves a diverse range of industries including personal care, health care, crop care, and industrial chemicals, providing innovative solutions that enhance product performance and sustainability.
Average Trading Volume: 857,922
Technical Sentiment Signal: Strong Sell
Current Market Cap: £3.87B
For a thorough assessment of CRDA stock, go to TipRanks’ Stock Analysis page.